352 related articles for article (PubMed ID: 22936501)
1. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and biological evaluation of [188Re(N)(cys ∼)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals.
Thieme S; Agostini S; Bergmann R; Pietzsch J; Pietzsch HJ; Carta D; Salvarese N; Refosco F; Bolzati C
Nucl Med Biol; 2011 Apr; 38(3):399-415. PubMed ID: 21492789
[TBL] [Abstract][Full Text] [Related]
3. Reliable preparation of 99mTc (V) DMSA by a simple modified method using a commercial kit for 99mTc (III) DMSA.
Washburn LC; Biniakiewicz DS; Maxon HR
Nucl Med Biol; 1995 Jul; 22(5):689-91. PubMed ID: 7581181
[TBL] [Abstract][Full Text] [Related]
4. Preparation and biological characterization of isomeric 188Re(V) oxocomplexes with tetradentate S4 ligands derived from meso-dimercaptosuccinic acid for labeling of biomolecules.
Seifert S; Heinrich T; Jentschel C; Smuda C; Bergmann R; Pietzsch HJ
Bioconjug Chem; 2006; 17(6):1601-6. PubMed ID: 17105241
[TBL] [Abstract][Full Text] [Related]
5. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor.
Park JY; Lee TS; Choi TH; Cheon GJ; Choi CW; Awh OD
Nucl Med Biol; 2007 Nov; 34(8):1029-36. PubMed ID: 17998108
[TBL] [Abstract][Full Text] [Related]
7. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
8. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
9. Preparation of [186Re]Re-DMSA and its bio-distribution studies.
Kothari K; Pillai MR; Unni PR; Shimpi HH; Noronha OP; Samuel AM
Appl Radiat Isot; 1999 Jul; 51(1):43-9. PubMed ID: 10376320
[TBL] [Abstract][Full Text] [Related]
10. Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complex.
Singh J; Reghebi K; Lazarus CR; Clarke SE; Callahan AP; Knapp FF; Blower PJ
Nucl Med Commun; 1993 Mar; 14(3):197-203. PubMed ID: 8384352
[TBL] [Abstract][Full Text] [Related]
11. PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals.
Boschi A; Massi A; Uccelli L; Pasquali M; Duatti A
Nucl Med Biol; 2010 Nov; 37(8):927-34. PubMed ID: 21055623
[TBL] [Abstract][Full Text] [Related]
12. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I
Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
[TBL] [Abstract][Full Text] [Related]
13. The 188Re(III)-EDTA complex--a multipurpose starting material for the preparation of relevant 188Re complexes under mild conditions.
Seifert S; Pietzsch HJ
Appl Radiat Isot; 2006 Feb; 64(2):223-7. PubMed ID: 16198583
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
Chauhan UP; Babbar A; Kashyap R; Prakash R
Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: an experimental study.
Ercan MT; Gülaldi NC; Unsal IS; Aydin M; Peksoy I; Hasçelik Z
Ann Nucl Med; 1996 Nov; 10(4):419-23. PubMed ID: 9006727
[TBL] [Abstract][Full Text] [Related]
16. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake.
Dadachova E; Chapman J
Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
18. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid.
Blower PJ; Singh J; Clarke SE
J Nucl Med; 1991 May; 32(5):845-9. PubMed ID: 1850782
[TBL] [Abstract][Full Text] [Related]
19. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
20. A new technique of 99mTc-ciprofloxacin kit preparation.
Kleisner I; Komarek P; Komarkova I; Konopkova M
Nuklearmedizin; 2002 Oct; 41(5):224-9. PubMed ID: 12418309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]